4DMedical, a Melbourne, Australia-based medical technology company, has secured over US$100 million (AU$150 million) in funding.
Investors
The funding was supported by a mix of new global institutional investors, with participation from existing shareholders.
4DMedical Use of Funds
The new funding will accelerate U.S. adoption of CT:VQ, support training and seamless integration into clinical workflows, drive ongoing research and development to expand 4DMedical’s product capabilities, and enhance operational scalability to sustain long-term clinical partnerships.
About 4DMedical
4DMedical is a technology company specializing in software-based respiratory imaging. Its flagship product, CT:VQ, is an imaging SaaS solution that provides ventilation and perfusion insights from CT imaging and is designed to integrate with existing hospital infrastructure. With offices in Melbourne, Australia and Los Angeles, California, the technology has deployed at leading U.S. academic medical centers, including Stanford, the Cleveland Clinic, the University of Miami, and UC San Diego Health.
Funding Details
Company: 4DMedical Limited
Raised: $100.0M
Round: Institutional Placement
Funding Date: January 2026
Lead Investor: Undisclosed
Additional Investors:
Company Website: https://4dmedical.com/
Software Category: Medical Imaging / SaaS
Source: https://www.prnewswire.com/apac/news-releases/4dmedical-secures-us100-million-funding-to-accelerate-us-expansion-and-increase-technology-dominance-in-software-based-lung-imaging-302665063.html